255641001: Caffeine (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\inhibiteur d'hydrolase\Phosphodiesterase inhibitor\Caffeine

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Purine and/or purine derivative\Xanthine and/or xanthine derivative (substance)\Xanthine derivative (substance)\Methylated xanthine derivative (substance)\Caffeine

\substance catégorisée selon sa fonction\phytochimique\Caffeine

\Material (substance)\matière naturelle\matière organique naturelle\matériel végétal\phytochimique\Caffeine

\Biological substance\matière organique naturelle\matériel végétal\phytochimique\Caffeine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Caffeine	est un(e) (attribut)	Enzyme inhibitor	false	Inferred relationship	Some
Caffeine	est un(e) (attribut)	Psychostimulant (substance)	true	Inferred relationship	Some
Caffeine	est un(e) (attribut)	Xanthine	false	Inferred relationship	Some
Caffeine	est un(e) (attribut)	Central nervous system agent (substance)	false	Inferred relationship	Some
Caffeine	est un(e) (attribut)	Drug allergen (substance)	false	Inferred relationship	Some
Caffeine	est un(e) (attribut)	Methylated xanthine derivative (substance)	true	Inferred relationship	Some
Caffeine	est un(e) (attribut)	Central respiratory stimulant (substance)	false	Inferred relationship	Some
Caffeine	est un(e) (attribut)	Phosphodiesterase inhibitor	true	Inferred relationship	Some
Caffeine	est un(e) (attribut)	phytochimique	true	Inferred relationship	Some
Caffeine	Has disposition (attribute)	Phosphodiesterase inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	False	Caffeine	Inferred relationship	Some	2
Acetaminophen 500 mg and caffeine 65 mg oral tablet	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	1
Acetaminophen 500 mg and caffeine 65 mg oral tablet	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Acetaminophen 450 mg and caffeine 30 mg oral tablet	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	1
Acetaminophen 450 mg and caffeine 30 mg oral tablet	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug)	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	2
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	False	Caffeine	Inferred relationship	Some	2
Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg oral capsule	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	1
Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg oral capsule	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Acetaminophen 500 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug)	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	1
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Caffeine	Inferred relationship	Some	2
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	1
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	1
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Acetaminophen 356.4 mg and caffeine 30 mg and dihydrocodeine tartrate 16 mg oral capsule	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	2
Acetaminophen 356.4 mg and caffeine 30 mg and dihydrocodeine tartrate 16 mg oral capsule	Has basis of strength substance (attribute)	False	Caffeine	Inferred relationship	Some	2
Acetaminophen 250 mg and aspirin 250 mg and caffeine 65 mg oral tablet	a pour principe actif (attribut)	False	Caffeine	Inferred relationship	Some	1
Acetaminophen 250 mg and aspirin 250 mg and caffeine 65 mg oral tablet	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule	Has basis of strength substance (attribute)	False	Caffeine	Inferred relationship	Some	2
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has basis of strength substance (attribute)	False	Caffeine	Inferred relationship	Some	3
Acetaminophen 250 mg and aspirin 250 mg and caffeine 65 mg oral tablet	Has basis of strength substance (attribute)	False	Caffeine	Inferred relationship	Some	3
caféine monohydrate	est un(e) (attribut)	False	Caffeine	Inferred relationship	Some
Caffeine hydrate	est un(e) (attribut)	False	Caffeine	Inferred relationship	Some
Management of caffeine intake (procedure)	substance utilisée (attribut)	True	Caffeine	Inferred relationship	Some	1
Caffeine citrate	Is modification of (attribute)	True	Caffeine	Inferred relationship	Some
Caffeinated coffee	Is modification of (attribute)	True	Caffeine	Inferred relationship	Some
Caffeine hydrate	Is modification of (attribute)	True	Caffeine	Inferred relationship	Some
caféine monohydrate	Is modification of (attribute)	True	Caffeine	Inferred relationship	Some
Caffeinated soft drinks	Is modification of (attribute)	False	Caffeine	Inferred relationship	Some
Product containing caffeine and codeine and paracetamol in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing caffeine and codeine and paracetamol (medicinal product)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet	Has basis of strength substance (attribute)	False	Caffeine	Inferred relationship	Some	3
Caffeine- and sodium benzoate-containing product in parenteral dose form	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	2
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository	Has basis of strength substance (attribute)	True	Caffeine	Inferred relationship	Some	1
Caffeine 100 mg and ergotamine tartrate 2 mg rectal suppository	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Product containing caffeine and ergotamine in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	3
Acetaminophen- and aspirin- and caffeine-containing product in oral dose form	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Aspirin 389 mg and caffeine 32.4 mg and propoxyphene hydrochloride 65 mg oral capsule	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	2
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	2
Aspirin- and butalbital- and caffeine-containing product in oral dose form	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing aspirin and butalbital and caffeine and codeine (medicinal product)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing aspirin and caffeine and orphenadrine in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing aspirin and caffeine and dihydrocodeine (medicinal product)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing aspirin and caffeine and dihydrocodeine in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	2
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	2
Aspirin- and butalbital- and caffeine- and codeine-containing product in oral dose form	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	3
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	3
Acetaminophen 356.4 mg and caffeine 30 mg and dihydrocodeine tartrate 16 mg oral capsule	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	2
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	2
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	2
Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	3
Acetaminophen 450 mg and caffeine 30 mg oral tablet	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Acetaminophen 450 mg and caffeine 25 mg oral tablet	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	2
Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Acetaminophen 250 mg and aspirin 250 mg and caffeine 65 mg oral tablet	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	3
Acetaminophen 500 mg and caffeine 65 mg oral tablet	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	3
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	3
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Has precise active ingredient	False	Caffeine	Inferred relationship	Some	3
Acetaminophen 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Acetaminophen 500 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Product containing butalbital and caffeine and codeine and paracetamol (medicinal product)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing caffeine and dihydrocodeine and paracetamol (medicinal product)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing caffeine and dihydrocodeine and paracetamol in oral dose form (medicinal product form)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Caffeine	Inferred relationship	Some	1
Product containing caffeine and isometheptene and paracetamol (medicinal product)	a pour principe actif (attribut)	True	Caffeine	Inferred relationship	Some	1

Start Previous Page 3 of 3

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
380891010	Caffeine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
562261000241111	caféine (substance)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
646709011	Caffeine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
796671000172110	caféine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)